AR222834A1 - Procedimiento para la preparacion de derivados de 2-nitroimidazol - Google Patents

Procedimiento para la preparacion de derivados de 2-nitroimidazol

Info

Publication number
AR222834A1
AR222834A1 AR277867A AR27786779A AR222834A1 AR 222834 A1 AR222834 A1 AR 222834A1 AR 277867 A AR277867 A AR 277867A AR 27786779 A AR27786779 A AR 27786779A AR 222834 A1 AR222834 A1 AR 222834A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
nitroimidazole derivatives
nitroimidazole
derivatives
Prior art date
Application number
AR277867A
Other languages
English (en)
Spanish (es)
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Application granted granted Critical
Publication of AR222834A1 publication Critical patent/AR222834A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
AR277867A 1978-08-29 1979-08-27 Procedimiento para la preparacion de derivados de 2-nitroimidazol AR222834A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93771578A 1978-08-29 1978-08-29
US06/018,023 US4199592A (en) 1978-08-29 1979-03-06 Antiinflammatory 4,5-diaryl-2-nitroimidazoles

Publications (1)

Publication Number Publication Date
AR222834A1 true AR222834A1 (es) 1981-06-30

Family

ID=26690639

Family Applications (1)

Application Number Title Priority Date Filing Date
AR277867A AR222834A1 (es) 1978-08-29 1979-08-27 Procedimiento para la preparacion de derivados de 2-nitroimidazol

Country Status (17)

Country Link
US (1) US4199592A (el)
EP (1) EP0008755B1 (el)
AR (1) AR222834A1 (el)
AU (1) AU525866B2 (el)
CA (1) CA1131229A (el)
DE (1) DE2962568D1 (el)
DK (1) DK281079A (el)
ES (1) ES483700A1 (el)
FI (1) FI69451C (el)
GR (1) GR71198B (el)
IE (1) IE48935B1 (el)
IL (1) IL58123A (el)
MX (1) MX6046E (el)
NO (1) NO152215C (el)
PH (1) PH14620A (el)
PT (1) PT70128A (el)
YU (1) YU209979A (el)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348404A (en) * 1980-07-21 1982-09-07 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-α-polyfluoroalkyl-1H-imidazole-2-methanamines
US4462992A (en) * 1982-02-08 1984-07-31 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US4503065A (en) * 1982-08-03 1985-03-05 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
EP0117485A3 (de) * 1983-02-28 1985-01-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyridin-, Pyrazin- und Pyrimidinderivate und deren Verwendung als fungizide Wirkstoffe
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5670527A (en) * 1993-07-16 1997-09-23 Smithkline Beecham Corporation Pyridyl imidazole compounds and compositions
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US5739143A (en) * 1995-06-07 1998-04-14 Smithkline Beecham Corporation Imidazole compounds and compositions
US6369068B1 (en) 1995-06-07 2002-04-09 Smithkline Beecham Corporation Amino substituted pyrimidine containing compounds
ZA9610687B (en) 1995-12-22 1997-09-29 Smithkline Beecham Corp Novel synthesis.
AP9700912A0 (en) 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
US5756499A (en) * 1996-01-11 1998-05-26 Smithkline Beecham Corporation Substituted imidazole compounds
ZA97175B (en) * 1996-01-11 1997-11-04 Smithkline Beecham Corp Novel substituted imidazole compounds.
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
WO1997035856A1 (en) * 1996-03-25 1997-10-02 Smithkline Beecham Corporation Novel treatment for cns injuries
EP0956018A4 (en) 1996-08-21 2000-01-12 Smithkline Beecham Corp IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE
US5929076A (en) * 1997-01-10 1999-07-27 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
US20020156104A1 (en) 1997-06-13 2002-10-24 Jerry L. Adams Novel pyrazole and pyrazoline substituted compounds
US6610695B1 (en) 1997-06-19 2003-08-26 Smithkline Beecham Corporation Aryloxy substituted pyrimidine imidazole compounds
US6562832B1 (en) 1997-07-02 2003-05-13 Smithkline Beecham Corporation Substituted imidazole compounds
US7301021B2 (en) * 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
AU8381098A (en) 1997-07-02 1999-01-25 Smithkline Beecham Corporation Novel cycloalkyl substituted imidazoles
US6489325B1 (en) 1998-07-01 2002-12-03 Smithkline Beecham Corporation Substituted imidazole compounds
TW517055B (en) 1997-07-02 2003-01-11 Smithkline Beecham Corp Novel substituted imidazole compounds
JP2001518507A (ja) 1997-10-08 2001-10-16 スミスクライン・ビーチャム・コーポレイション 新規シクロアルケニル置換化合物
DE69821132T2 (de) * 1997-10-27 2004-10-21 Takeda Chemical Industries Ltd 1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes
WO1999032121A1 (en) 1997-12-19 1999-07-01 Smithkline Beecham Corporation Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
EP1080087A4 (en) 1998-05-22 2001-11-21 Smithkline Beecham Corp NEW 2-ALKYL-SUBSTITUTED IMIDAZOLES
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
EP1112070B1 (en) * 1998-08-20 2004-05-12 Smithkline Beecham Corporation Novel substituted triazole compounds
JP2002528506A (ja) * 1998-11-04 2002-09-03 スミスクライン・ビーチャム・コーポレイション ピリジン−4−イルまたはピリミジン−4−イル置換ピラジン
US6239279B1 (en) 1998-12-16 2001-05-29 Smithkline Beecham Corporation Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
ES2241675T3 (es) 1999-11-23 2005-11-01 Smithkline Beecham Corporation Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de cspb/p38 quinasa.
ES2249309T3 (es) 1999-11-23 2006-04-01 Smithkline Beecham Corp Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa.
US6759410B1 (en) * 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
EP1235814B1 (en) 1999-11-23 2004-11-03 Smithkline Beecham Corporation 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
US7235551B2 (en) * 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
CZ20031125A3 (cs) * 2000-10-23 2003-10-15 Smithkline Beecham Corporation Nové sloučeniny
UY29440A1 (es) 2005-03-25 2006-10-02 Glaxo Group Ltd Nuevos compuestos
MX2007012951A (es) * 2005-03-25 2008-01-11 Glaxo Group Ltd Procedimiento para preparar derivados de pirido[2,3-d] pirimidin-7-ona y 3,4-dihidropirimidino[4,5-d]pirimidin-2(1h)-ona.
MD4150C1 (ro) * 2011-10-11 2012-09-30 Институт Химии Академии Наук Молдовы Procedeu de obţinere a compuşilor coordinativi ai Co(II), Ni(II) şi Zn(II) cu 2-nitro-4,5-difenilimidazol pornind de la 4,5-difenilimidazol şi nitraţii metalelor respective
MD4178C1 (ro) * 2012-02-27 2013-02-28 Институт Химии Академии Наук Молдовы Procedeu de obţinere a 2-nitro-4,5-difenilimidazolului

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL124627C (el) * 1964-08-12
GB1155580A (en) * 1965-10-21 1969-06-18 Geigy Ag J R New Imidazole Derivatives their Production and Use
US3651080A (en) * 1969-11-07 1972-03-21 Ciba Geigy Corp Certain substituted 2-alkylmercaptoimidazole derivatives
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
US3901908A (en) * 1970-12-28 1975-08-26 Ciba Geigy Corp 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
US3929807A (en) * 1971-05-10 1975-12-30 Ciba Geigy Corp 2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
DE2229248C3 (de) * 1971-07-30 1980-03-27 Gruppo Lepetit S.P.A., Mailand (Italien) 5-Iminomethyl-2-nitroimidazoI-Derivate und Verfahren zu deren Herstellung
DK16778A (da) * 1977-02-09 1978-08-10 Du Pont Imidazolderivater deres anvendelser og fremstilling
US4182769A (en) * 1977-02-09 1980-01-08 E. I. Du Pont De Nemours And Company Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones

Also Published As

Publication number Publication date
YU209979A (en) 1983-04-30
AU525866B2 (en) 1982-12-02
EP0008755A1 (en) 1980-03-19
IL58123A (en) 1983-05-15
DE2962568D1 (en) 1982-06-03
PH14620A (en) 1981-10-12
EP0008755B1 (en) 1982-04-21
FI69451C (fi) 1986-02-10
AU5035479A (en) 1980-03-06
IE791643L (en) 1980-02-29
FI792683A (fi) 1980-03-01
GR71198B (el) 1983-04-11
ES483700A1 (es) 1980-09-01
DK281079A (da) 1980-03-01
NO152215C (no) 1985-08-28
PT70128A (en) 1979-09-01
MX6046E (es) 1984-10-11
FI69451B (fi) 1985-10-31
IE48935B1 (en) 1985-06-26
NO152215B (no) 1985-05-13
CA1131229A (en) 1982-09-07
US4199592A (en) 1980-04-22
NO792787L (no) 1980-03-03
IL58123A0 (en) 1979-12-30

Similar Documents

Publication Publication Date Title
AR222834A1 (es) Procedimiento para la preparacion de derivados de 2-nitroimidazol
MX6749E (es) Procedimiento para la preparacion de derivados de tetrazolilalcoxicarboestirilo
MX5631E (es) Procedimiento para la preparacion de acil-anilinas
MX7623E (es) Procedimiento para la preparacion de 4-amino-5-alquil-sulfonil-orto-anisamidas
AR227637A1 (es) Procedimiento para la preparacion de derivados de n-(fenoxialquil)imidazoles
MX5578E (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
MX5890E (es) Procedimiento para la preparacion de compuestos de difenileter
AR221428A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil-y de pirrolidinilmetil-benzamidas
AR227379A1 (es) Procedimiento para la preparacion de 1-aril-2-imidazolil vinileteres
MX5509E (es) Procedimiento para la preparacion de n-halogenoacetil-fenilaminocarboniloximas
MX5898E (es) Procedimiento para la preparacion de 2-amino-4-pirimidonas
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
MX5594E (es) Procedimiento mejorado para la preparacion de derivados de n-trifluoroacetil-n-fosfonometilglicinatos
ES485567A0 (es) Procedimiento para la preparacion de azolilcetales
MX5909E (es) Procedimiento mejorado para la preparacion de ciclohexanona
MX149694A (es) Procedimiento para la preparacion de trialcoxisilanos de fenoxialquilo
ES484342A0 (es) Procedimiento para la preparacion de propenilensulfona
MX5955E (es) Procedimiento para la preparacion de derivados de piridoxina
MX6232E (es) Procedimiento para la preparacion de auronas substituidas
MX5987E (es) Procedimiento para la preparacion de derivados de la l-cisteina
MX5605E (es) Procedimiento mejorado para la preparacion de 2-isopropilaminopirimidina
MX5674E (es) Procedimiento para la preparacion de derivados de la butenofenona
MX5445E (es) Procedimiento para la preparacion de derivados de isotiocianobenzotiazol
ES490201A0 (es) Procedimiento mejorado para la preparacion de sulfonilureas
AR220367A1 (es) Procedimiento de preparacion de derivados de la 2-n-bencilidenamino-sulfamoil-benzamida